[Narcolepsy: a new perspective on diagnosis and treatment]

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):856-61.
[Article in Dutch]

Abstract

The 5 classic symptoms of narcolepsy are excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations and disturbed nocturnal sleep. The presence of cataplexy is strongly associated with a deficiency of the neuropeptide hypocretin. This discovery has led to new diagnostic subclassifications: narcolepsy without cataplexy, which can be demonstrated by a multiple sleep latency test, and narcolepsy with cataplexy, which can be confirmed with a multiple sleep latency test or a cerebrospinal fluid deficiency of hypocretin I. Various treatment options are available, including psychostimulants and gamma hydroxybuterate.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cataplexy / complications
  • Cataplexy / diagnosis*
  • Cataplexy / drug therapy*
  • Central Nervous System Stimulants / therapeutic use*
  • Diagnosis, Differential
  • Humans
  • Intracellular Signaling Peptides and Proteins / deficiency
  • Narcolepsy / complications
  • Narcolepsy / diagnosis*
  • Narcolepsy / drug therapy*
  • Neuropeptides / deficiency
  • Orexins
  • Sleep, REM / drug effects
  • Sodium Oxybate / therapeutic use

Substances

  • Central Nervous System Stimulants
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Sodium Oxybate